Ranok Therapeutics

About:

Ranok Therapeutics is a biotechnology company that is pioneering an innovative targeted protein degradation technology.

Website: http://www.ranoktherapeutics.com/

Twitter/X: RanokTx

Top Investors: Lapam Capital, Wu Capital, TF Capital, Shanghai Healthcare Capital, Med-Fine Capital

Description:

Ranok Therapeutics is a biotechnology company that is developing a novel targeted protein degradation technology to aid in the discovery and development of novel therapeutics. Ranok's TPD technology engages various underlying biological processes and outperforms competing TPD approaches. Ranok's pipeline contains both well-validated and novel drug targets involved in cancer and other diseases with significant unmet medical needs. Ranok is dedicated to developing the next generation of cancer therapies that are both safer and more effective.

Total Funding Amount:

$50M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2018-01-01

Contact Email:

bd(AT)ranoktherapeutics.com

Founders:

Kevin P. Foley`, Weiwen Ying

Number of Employees:

11-50

Last Funding Date:

2021-08-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai